(SEPTEMBER 10, 2023) Infectious disease specialist Kristen Pierce, M.D., professor of medicine, is principal investigator for a clinical study at the Vaccine Testing Center and the UVM Medical Center of a Pfizer vaccine to protect against Lyme disease, VT Digger reports.
Infectious disease specialist Kristen Pierce, M.D., professor of medicine, principal investigator of a Phase 3 Lyme disease vaccine trial
(SEPTEMBER 10, 2023) Infectious disease specialist Kristen Pierce, M.D., professor of medicine, is principal investigator for a clinical study at the Vaccine Testing Center and the UVM Medical Center of a Pfizer vaccine to protect against Lyme disease, VT Digger reports.
The currently active Phase 3 trial will test whether three doses of the vaccine and a booster do better at protecting participants from Lyme disease than the same number of doses of a saline placebo. The study will take place over 30 months and involve at least seven visits to a clinic at the Burlington hospital, as well as four or five blood draws. Due to the large response to requests for volunteers, the study is no longer recruiting participants.
Read full story
at
VT Digger